Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.97 USD | +0.02% | -.--% | +240.87% |
Financials (USD)
Sales 2025 * | - | Sales 2026 * | - | Capitalization | 4.46B |
---|---|---|---|---|---|
Net income 2025 * | - | Net income 2026 * | - | EV / Sales 2025 * | - |
Net cash position 2025 * | - | Net cash position 2026 * | - | EV / Sales 2026 * | - |
P/E ratio 2025 * |
-
| P/E ratio 2026 * |
-
| Employees | 142 |
Yield 2025 * |
-
| Yield 2026 * |
-
| Free-Float | 96.04% |
Latest transcript on Alpine Immune Sciences, Inc.
1 day | +0.02% | ||
1 month | +0.51% | ||
3 months | +75.59% | ||
6 months | +293.28% | ||
Current year | +240.87% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.64% | 4 M€ | -5.15% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +9.52% | - |
1st Jan change | Capi. | |
---|---|---|
+240.87% | 4.46B | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- ALPN Stock